Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.81B |
| 3 |
Marvell Technology
MRVL
|
+$1.71B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.11B |
| 5 |
Coca-Cola
KO
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.79B |
| 2 |
SNDK
Sandisk
SNDK
|
+$887M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$762M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$651M |
| 5 |
Vertiv
VRT
|
+$587M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.81% |
| 2 | Financials | 12.23% |
| 3 | Industrials | 9.61% |
| 4 | Healthcare | 9.36% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Dermata Therapeutics
DRMA
$6.09M
| $26.1K | ﹤0.01% |
20,203
-28,131
| -58% | -$35.4K |
|
4352
60 Degrees Pharmaceuticals
SXTP
$3.27M
| $25.6K | ﹤0.01% |
14,551
-1,744
| -11% | -$2.81K |
|
|
GCL
4353
GCL Global Holdings
GCL
$76.7M
| $25.6K | ﹤0.01% |
56,742
-20,327
| -26% | -$10.4K |
|
4354
Iveda Solutions
IVDA
$3.54M
| $25.4K | ﹤0.01% |
77,675
-195,521
| -72% | -$62.5K |
|
|
SNT
4355
Senstar Technologies
SNT
$40.1M
| $25.3K | ﹤0.01% |
13,114
-2,403
| -15% | -$6.38K |
|
|
RENX
4356
RenX Enterprises
RENX
$5.69M
| $24.8K | ﹤0.01% |
+13,182
| New | +$27.5K |
|
|
GRI
4357
GRI Bio
GRI
$5.01M
| $24.5K | ﹤0.01% |
13,869
-4,569
| -25% | -$10.1K |
|
4358
OLB
OLB
$6.61M
| $24.3K | ﹤0.01% |
63,804
-61,621
| -49% | -$28.2K |
|
|
HERE
4359
Here Group Ltd
HERE
$103M
| $24.3K | ﹤0.01% |
12,461
-1,683
| -12% | -$4.71K |
|
|
BTOC
4360
Armlogi Holding Corp
BTOC
$13.9M
| $24.1K | ﹤0.01% |
80,285
-128,819
| -62% | -$38.4K |
|
|
OPENZ
4361
Opendoor Technologies Inc Series Z Warrants
OPENZ
$3.64M
| $24K | ﹤0.01% |
100,175
-1
| -0% | – |
|
|
VSEE
4362
DELISTED
VSEE HEALTH INC
VSEE
| $23.9K | ﹤0.01% |
207,081
-230,518
| -53% | -$41.6K |
|
|
XCH
4363
XCHG Ltd
XCH
$15M
| $23.9K | ﹤0.01% |
+1,512
| New | +$26K |
|
4364
New Concept Energy
GBR
$4M
| $22.8K | ﹤0.01% |
32,945
-5,148
| -14% | -$3.98K |
|
|
BDMD
4365
Baird Medical Investment Holdings
BDMD
$37.4M
| $22.5K | ﹤0.01% |
19,596
-5,846
| -23% | -$9.09K |
|
|
HCWC
4366
Healthy Choice Wellness
HCWC
$6.48M
| $22.5K | ﹤0.01% |
3,311
-2,060
| -38% | -$19.1K |
|
|
INCR
4367
Intercure
INCR
$78.9M
| $22.4K | ﹤0.01% |
4,071
-437
| -10% | -$1.94K |
|
|
AHG
4368
Akso Health Group
AHG
$749M
| $22.3K | ﹤0.01% |
14,973
| – | – |
|
4369
Healthcare Triangle
HCTI
$12.6M
| $21.7K | ﹤0.01% |
11,975
-620
| -5% | -$1.43K |
|
|
CHGA
4370
Change Agents Corp
CHGA
$2.56M
| $21.6K | ﹤0.01% |
3,707
+610
| +20% | +$4.71K |
|
|
SAGT
4371
Sagtec Global
SAGT
$11.7M
| $20.1K | ﹤0.01% |
16,064
| – | – |
|
4372
Netcapital
NCPL
$4.93M
| $20.1K | ﹤0.01% |
37,439
-34,775
| -48% | -$20.7K |
|
4373
Shengfeng Development Ltd
SFWL
$73.5M
| $20K | ﹤0.01% |
22,048
-1,442
| -6% | -$1.31K |
|
4374
Investcorp Credit Management BDC
ICMB
$12.3M
| $19.8K | ﹤0.01% |
16,938
| – | – |
|
|
QTEX
4375
QTREX Quantum
QTEX
$54.9M
| $19.8K | ﹤0.01% |
+13,727
| New | +$14.4K |
|
Similar funds
Geode Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Geode Capital Management held 4,628 positions worth $1.88T, up 17% from $1.61T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Geode Capital Management's Q2 2026 filing shows 115 new, 3,002 increased, 1,183 reduced and 181 closed positions. Its largest new stake was SpaceX: 13,529,026 shares worth $2.31B. The largest sale was Honeywell, an estimated $1.79B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Geode Capital Management's largest Q2 2026 buy was SpaceX: 13,529,026 shares worth $2.31B.
- Geode Capital Management added most to Marvell Technology in Q2 2026, an estimated $1.71B increase.
- Geode Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $1.79B.
- Geode Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $762M.
- Geode Capital Management's ten largest holdings make up 31% of its $1.88T portfolio in Q2 2026.
- Geode Capital Management opened 115 new positions and closed 181 in Q2 2026.
- Geode Capital Management's portfolio value rose 17% quarter-over-quarter to $1.88T.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.